Treatment Recommendations for Psychedelic-assisted Therapy

Switzerland played an early and notable role in the 21st-century revival of psychedelic science, which has generated growing global interest in using psychedelics for research and therapy. In 2023, the Swiss Interest Group for Psychedelic-assisted Therapy was formed to establish a clear, widely accepted framework for such work. The group produced a first draft of treatment recommendations (S1 guidelines) that will be regularly updated to reflect new research and therapeutic findings.

Study at a glance

Abstract

Switzerland's early contributions to the 'psychedelic renaissance', the revival of psychedelic science starting in the early 21st century, might be particularly noteworthy given the growing global interest in using psychedelics for research and therapy.In 2023, the Swiss Interest Group for Psychedelic-assisted Therapy was established to provide a clear and widely accepted framework for work related to psychedelic-assisted therapy.Members of this group created a first draft of treatment recommendations (S1 guidelines).These recommendations will be continuously updated to incorporate new findings in research and therapy.